Three Different Human Tumor Cell Lines Contain Different Oncogenes
Overview
Authors
Affiliations
We have obtained foci of transformed mouse cells after transfection of human DNA from colon and bladder carcinoma cell lines and a promyelocytic leukemia cell line. These foci can be shown to contain a large number of human DNA sequences by use of highly repetitive human DNA sequence probes. Cell DNA from primary foci can be used in a subsequent cycle of transfection resulting in secondary foci that contain relatively little human DNA. Secondary foci appear to contain only the human sequences proximal to those responsible for the transformed phenotype. A set of characteristic DNA restriction fragments is found in common among secondary foci derived from each tumor cell line DNA. Comparison of the common DNA fragments found in secondary foci derived from three different human tumor cell lines indicates that these three cell lines contain three different transforming genes.
Exploiting F NMR in a Multiplexed Assay for Small GTPase Activity.
Bhinderwala F, Gronenborn A J Am Chem Soc. 2024; 147(1):1028-1033.
PMID: 39693054 PMC: 11719398. DOI: 10.1021/jacs.4c14294.
"Undruggable KRAS": druggable after all.
Cox A, Der C Genes Dev. 2024; 39(1-2):132-162.
PMID: 39638567 PMC: 11789494. DOI: 10.1101/gad.352081.124.
Base excision repair accessory factors in senescence avoidance and resistance to treatments.
Vickridge E, Faraco C, Nepveu A Cancer Drug Resist. 2022; 5(3):703-720.
PMID: 36176767 PMC: 9511810. DOI: 10.20517/cdr.2022.36.
The path to the clinic: a comprehensive review on direct KRAS inhibitors.
Kwan A, Piazza G, Keeton A, Leite C J Exp Clin Cancer Res. 2022; 41(1):27.
PMID: 35045886 PMC: 8767686. DOI: 10.1186/s13046-021-02225-w.
The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis.
Ochieng J, Nangami G, Ogunkua O, Miousse I, Koturbash I, Odero-Marah V Carcinogenesis. 2015; 36 Suppl 1:S128-59.
PMID: 26106135 PMC: 4565611. DOI: 10.1093/carcin/bgv034.